MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  


Evista (raloxifene hydrochloride)

Company: Eli Lilly
Approval Status: Approved September 1999
Treatment for: For the treatment of osteoporosis in postmenopausal women.
Areas: Diabetes / Endocrinology; Musculoskeletal; Pregnancy & Gynecology
Possible similar drugs: Evista; Evista

| General Information | Mechanism of Action |


General Information

Tablet of raloxifene hydrochloride for the treatment of osteoporosis in post-menopausal women.


Mechanism of Action

Tablet, 60 mg.




< back to top

Evista Drug Information

The Evista drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.





MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.